×
About 10,343 results

ALLMedicine™ Calcitonin Center

Research & Reviews  4,905 results

CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC...
https://doi.org/10.1177/0333102420981688
Cephalalgia : an International Journal of Headache; Kopruszinski CM, Turnes JM et. al.

Feb 22nd, 2021 - Determine the role of calcitonin-gene related peptide in promoting post-traumatic headache and dysregulation of central pain modulation induced by mild traumatic brain injury in mice. Mild traumatic brain injury was induced in lightly anesthetized...

The expression of substance P and calcitonin gene-related peptide is associated with th...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898744
BMC Musculoskeletal Disorders; Han SH, Kim HK et. al.

Feb 22nd, 2021 - In this study, we investigated whether substance P (SP) or calcitonin gene-related peptide (CGRP) expression is associated with tendon degeneration in patients with lateral epicondylitis. Twenty-nine patients who underwent surgical treatment for l...

Delta opioid receptor regulation of CGRP dynamics in the trigeminal complex.
https://doi.org/10.1097/j.pain.0000000000002235
Pain Moye LS, Siegersma K et. al.

Feb 19th, 2021 - Migraine is highly prevalent and is the sixth leading cause worldwide for years lost to disability. Therapeutic options specifically targeting migraine are limited, and delta opioid receptor (DOP) agonists were recently identified as a promising p...

Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893711
Reproductive Biology and Endocrinology : RB&E; Xu X, Cai X et. al.

Feb 19th, 2021 - Accumulating data indicate that sensory nerve derived neuropeptides such as substance P and calcitonin gene related-protein (CGRP) can accelerate the progression of endometriosis via their respective receptors, so can agonists to their respective ...

Understanding the migraine treatment landscape prior to the introduction of calcitonin ...
https://doi.org/10.1111/head.14053
Headache Kawata AK, Shah N et. al.

Feb 17th, 2021 - Calcitonin gene-related peptide (CGRP) inhibitors were introduced in the United States (US) in 2018. To understand the changing patterns of preventive treatment following the introduction of these new agents, we must first characterize the pattern...

see more →

Guidelines  3 results

European headache federation guideline on the use of monoclonal antibodies acting on th...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734227
The Journal of Headache and Pain; Sacco S, Bendtsen L et. al.

Jan 17th, 2019 - Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and thr...

Consensus on management of advanced medullary thyroid carcinoma on behalf of the Workin...
https://doi.org/10.1007/s12094-015-1465-x
Clinical & Translational Oncology : Official Publication ... Grande E, Santamaría Sandi J et. al.

Dec 21st, 2015 - Of all thyroid cancers, <5 % are medullary (MTC). It is a well-characterized neuroendocrine tumor arising from calcitonin-secreting C cells, and RET gene plays a central role on its pathogeny. The electronic search was conducted using MEDLINE (Pub...

The treatment of symptomatic osteoporotic spinal compression fractures.
https://doi.org/10.5435/00124635-201103000-00007
The Journal of the American Academy of Orthopaedic Surgeons; Esses SI, McGuire R et. al.

Mar 3rd, 2011 - This clinical practice guideline is based on a series of systematic reviews of published studies on the treatment of symptomatic osteoporotic spinal compression fractures. Of 11 recommendations, one is strong; one, moderate; three, weak; and six, ...

see more →

Drugs  33 results see all →

Clinicaltrials.gov  5,119 results

CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC...
https://doi.org/10.1177/0333102420981688
Cephalalgia : an International Journal of Headache; Kopruszinski CM, Turnes JM et. al.

Feb 22nd, 2021 - Determine the role of calcitonin-gene related peptide in promoting post-traumatic headache and dysregulation of central pain modulation induced by mild traumatic brain injury in mice. Mild traumatic brain injury was induced in lightly anesthetized...

The expression of substance P and calcitonin gene-related peptide is associated with th...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898744
BMC Musculoskeletal Disorders; Han SH, Kim HK et. al.

Feb 22nd, 2021 - In this study, we investigated whether substance P (SP) or calcitonin gene-related peptide (CGRP) expression is associated with tendon degeneration in patients with lateral epicondylitis. Twenty-nine patients who underwent surgical treatment for l...

Delta opioid receptor regulation of CGRP dynamics in the trigeminal complex.
https://doi.org/10.1097/j.pain.0000000000002235
Pain Moye LS, Siegersma K et. al.

Feb 19th, 2021 - Migraine is highly prevalent and is the sixth leading cause worldwide for years lost to disability. Therapeutic options specifically targeting migraine are limited, and delta opioid receptor (DOP) agonists were recently identified as a promising p...

Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893711
Reproductive Biology and Endocrinology : RB&E; Xu X, Cai X et. al.

Feb 19th, 2021 - Accumulating data indicate that sensory nerve derived neuropeptides such as substance P and calcitonin gene related-protein (CGRP) can accelerate the progression of endometriosis via their respective receptors, so can agonists to their respective ...

Understanding the migraine treatment landscape prior to the introduction of calcitonin ...
https://doi.org/10.1111/head.14053
Headache Kawata AK, Shah N et. al.

Feb 17th, 2021 - Calcitonin gene-related peptide (CGRP) inhibitors were introduced in the United States (US) in 2018. To understand the changing patterns of preventive treatment following the introduction of these new agents, we must first characterize the pattern...

see more →

News  283 results

CGRP May Offer Both Migraine Treatment and Prevention
https://www.medscape.com/viewarticle/943042

Dec 21st, 2020 - Rimegepant (Nurtec ODT), the first calcitonin gene–related peptide (CGRP) receptor antagonist approved in the United States for the acute treatment of migraine, may help prevent migraine headaches as well. In a phase 2/3 study, oral rimegepant was...

CGRPs Promising for Prevention of Chronic Cluster Headache
https://www.staging.medscape.com/viewarticle/937760

Sep 20th, 2020 - Treatment with calcitonin gene-related peptide (CGRP) monoclonal antibodies may reduce the frequency of chronic cluster headache (CCH) attacks in patients with an inadequate response to other preventive medications, new research shows. In findings...

CGRPs Promising for Prevention of Chronic Cluster Headache
https://www.medscape.com/viewarticle/937760

Sep 20th, 2020 - Treatment with calcitonin gene-related peptide (CGRP) monoclonal antibodies may reduce the frequency of chronic cluster headache (CCH) attacks in patients with an inadequate response to other preventive medications, new research shows. In findings...

FDA Drug Approvals, Internal Medicine — 2020 Midyear Review
https://reference.staging.medscape.com/viewarticle/935373

Aug 13th, 2020 - Gastroenterology Pizensy (lactitol) Lactitol exerts an osmotic effect, causing an influx of water into the small intestine that results in a laxative effect in the colon. It is indicated for adults with chronic idiopathic constipation . Approval w...

Consistent Effects for Galcanezumab in Cluster Headache
https://www.medscape.com/viewarticle/932887

Jun 23rd, 2020 - Galcanezumab (Emgality, Eli Lilly and Co), the humanized monoclonal antibody that targets calcitonin gene–related peptide (CGRP), provides consistent improvements over time for patients with episodic cluster headache, new research suggests. A post...

see more →